Lung cancer treatment has evolved significantly over the years, with a focus on providing personalized care based on the type and stage of cancer. The standard care for lung cancer typically includes a combination of surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. These treatments are selected based on whether the lung cancer is classified as non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC), which are the two main types of the disease.

Surgery

Surgery is often the primary treatment for early-stage lung cancer. The goal is to remove the tumor and a margin of healthy tissue around it. Depending on the size and location of the tumor, the following procedures may be used:

  1. Lobectomy: Removal of one of the five lobes of the lungs.
  2. Pneumonectomy: Removal of an entire lung.
  3. Segmentectomy or Wedge Resection: Removal of a small part of the lung containing the tumor.

    4. Surgery is usually considered for non-small cell lung cancer (NSCLC) in stages I or II and sometimes in stage III if the cancer has not spread beyond the lung.

Chemotherapy

Chemotherapy involves using drugs to kill cancer cells throughout the body. It is often used in lung cancer as adjuvant therapy after surgery to eliminate any remaining cancer cells or as a primary treatment for more advanced lung cancer.

  • Adjuvant Chemotherapy: Administered after surgery to reduce the risk of recurrence.
  • Neoadjuvant Chemotherapy: Given before surgery to shrink tumors and make surgery more effective.
  • For Advanced Stages: Chemotherapy is often the first-line treatment for advanced NSCLC or small cell lung cancer (SCLC), which is generally more aggressive.

Common chemotherapy drugs for lung cancer include cisplatin, carboplatin, paclitaxel, and etoposide.

Radiation Therapy

Radiation therapy uses high-energy X-rays or other forms of radiation to kill cancer cells or shrink tumors. It's often used when surgery is not possible or as part of a combined treatment approach.

  • External Beam Radiation Therapy (EBRT): This is the most common type of radiation therapy for lung cancer, often used alongside chemotherapy (called chemoradiation).
  • Stereotactic Body Radiation Therapy (SBRT): A highly precise radiation therapy technique, often used for small, early-stage lung cancers that cannot be surgically removed.

Targeted Therapy

Targeted therapy works by specifically attacking cancer cells with particular genetic mutations, without harming normal cells. It is primarily used for NSCLC that has specific molecular characteristics, such as mutations in the EGFR, ALK, or ROS1 genes.

  • EGFR Inhibitors: Drugs like erlotinib and osimertinib are used to block the growth signals in cancers with EGFR mutations.
  • ALK Inhibitors: Alectinib or crizotinib are used for ALK-positive lung cancers.
Targeted therapy is usually recommended for patients whose tumors have specific genetic alterations and is often used when cancer has spread or returned after chemotherapy.

Immunotherapy

Immunotherapy has transformed lung cancer care, especially in patients with advanced-stage NSCLC. This treatment helps the body’s immune system identify and attack cancer cells.

  • PD-1/PD-L1 Inhibitors: Drugs like pembrolizumab (Keytruda) and nivolumab (Opdivo) are used to block proteins that prevent immune cells from attacking cancer cells. These are particularly effective for patients with high PD-L1 expression.
  • CTLA-4 Inhibitors: Drugs like ipilimumab can also be combined with PD-1 inhibitors to enhance the immune response against cancer.
Immunotherapy can be used as a first-line treatment for patients with metastatic NSCLC, depending on the PD-L1 status of the tumor, or in combination with chemotherapy.

Palliative Care

For patients with advanced-stage lung cancer, the focus may shift from curative treatments to palliative care, which aims to relieve symptoms and improve quality of life. Palliative treatments may include radiation or chemotherapy to shrink tumors that are causing pain, shortness of breath, or other symptoms, as well as medications to control pain and other side effects.

Follow-up and Surveillance

After completing treatment, patients are closely monitored to detect any signs of recurrence or new cancer. Regular check-ups, including imaging tests like CT scans, and lab work are part of the follow-up care routine for lung cancer patients.

Factors That Influence Treatment

  • Stage of the Cancer: Early-stage lung cancers are more likely to be treated with surgery, while advanced stages may require chemotherapy, radiation, or immunotherapy
  • Type of Lung Cancer: NSCLC and SCLC are treated differently. SCLC often requires more aggressive chemotherapy and radiation, while NSCLC may benefit from targeted therapy or immunotherapy.
  • Genetic Mutations: Personalized treatments based on genetic testing have become an important aspect of lung cancer care, particularly for NSCLC.

Conclusion:

The standard care for lung cancer depends on the type and stage of cancer, as well as the patient’s overall health and genetic factors. Surgery, chemotherapy, radiation, targeted therapy, and immunotherapy all play a role in lung cancer treatment. A personalized approach ensures that patients receive the most effective and appropriate care based on their specific diagnosis.

Find a study